Back to search results

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

Abroad (travel likely)Recruiting

Conditions

Transthyretin Cardiac Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Northwestern University, Evanston, Illinois, United States

  • Centre Hospitalier Universitaire de Toulouse, Toulouse, France

    Contact: Study coordinator (Olivier Lairez, MD, PhD)
    Contact: Principal Investigator (Olivier Lairez, MD, PhD)

  • Universitätsklinikum Bonn, Bonn, Germany

  • TUM Klinikum Deutsches Herzzentrum, München, Germany

    Contact: Study coordinator (Moritz von Scheidt, MD, PhD)
    Contact: Principal Investigator (Moritz von Scheidt, MD, PhD)

  • Hospital Universitario Son Llàtzer, Palma de Mallorca, Balearic Islands, Spain

    Contact: Study coordinator (Tomás Ripoll Vera, MD, PhD)
    Contact: Principal Investigator (Tomás Ripoll Vera, MD, PhD)
    Contact: Principal Investigator (María Eugenia Cisneros Barroso, MD, PhD)
    Ana María Far Riera, MD, PhD (Sub-investigator)

  • Hospital Universitario Donostia, San Sebastián, Guipúzcoa, Spain

  • Hospital Universitario Juan Ramón Jiménez, Huelva, Huelva, Spain

  • Queen Elizabeth University Hospital, Univeisity of Glasgow, Glasgow, United Kingdom

    Contact: Study coordinator (David Lowe, MD, MSc)
    Contact: Principal Investigator (David Lowe, MD, MSc)
Study leads

  • Pablo García Pavía, MD, PhD

    Principal Investigator

    Hospital Universitario Puerta de Hierro

View source on ClinicalTrials.gov(opens in a new tab)